rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
BLISS GVS PHARMA LTD. - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure<BR> Requirements) Regulations, 2015 For Setting Up "New State Of The Art Oral Solid Dosage<BR> Facility".
Download announcement < Back
16 Mar 2020
Pursuant to Regulation 30(6) read with Para B of Part A of Schedule III of SEBI (Listing Obligations&lt;BR&gt; and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company has&lt;BR&gt; completed the commissioning &amp;. qualification of Phase-I for its new state of the art multi-product&lt;BR&gt; facility situated at Palghar East in Maharashtra. This is the largest manufacturing unit of the Company&lt;BR&gt; in terms of planned production capacity when completed. Itis equipped with state of the art process&lt;BR&gt; equipment &amp; utilities with a large part of the manufacturing process automated for enhanced levels of productivity, efficiency &amp; compliance while reducing manual intervention.
View all announcements for BLISS GVS PHARMA LTD. Source: BSE India